首页> 外文期刊>Cancer genetics >LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13)
【24h】

LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13)

机译:通过RNA测序在动脉瘤性良性纤维组织细胞瘤中使用t(3; 11)(p21; q13)进行RNA测序鉴定了LAMTOR1-PRKCD和NUMA1-SFMBT1融合基因

获取原文
获取原文并翻译 | 示例
           

摘要

RNA sequencing of an aneurysmal benign fibrous histiocytoma with the karyotype 46,XY,t(3;11)(p21;q13),del(6)(p23)[17]/46,XY[2] showed that the t(3;11) generated two fusion genes: LAMTOR1-PRKCD and NUMA1-SFMBT1. RT-PCR together with Sanger sequencing verified the presence of fusion transcripts from both fusion genes. In the LAMTOR1-PRKCD fusion, the part of the PRKCD gene coding for the catalytic domain of the serine/threonine kinase is under control of the LAMTOR1 promoter. In the NUMA1-SFMBT1 fusion, the part of the SFMBT1 gene coding for two of four malignant brain tumor domains and the sterile alpha motif domain is controlled by the NUMA1 promoter. The data support a neoplastic genesis of aneurysmal benign fibrous histiocytoma and indicate a pathogenetic role for LAMTOR1-PRKCD and NUMA1-SFMBT1.
机译:核型46,XY,t(3; 11)(p21; q13),del(6)(p23)[17] / 46,XY [2]的动脉瘤良性纤维组织细胞瘤的RNA测序显示t(3 ; 11)产生了两个融合基因:LAMTOR1-PRKCD和NUMA1-SFMBT1。 RT-PCR与Sanger测序一起验证了两个融合基因均存在融合转录本。在LAMTOR1-PRKCD融合体中,PRKCD基因的编码丝氨酸/苏氨酸激酶催化域的部分处于LAMTOR1启动子的控制之下。在NUMA1-SFMBT1融合中,SFMBT1基因的一部分编码四个恶性脑肿瘤域中的两个域和无菌的alpha基序域,由NUMA1启动子控制。数据支持动脉瘤良性纤维组织细胞瘤的肿瘤发生,并表明LAMTOR1-PRKCD和NUMA1-SFMBT1的致病作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号